← Leaderboards
Clodia Osipo
Loyola University Chicago
$1,507,094
Attributed
$1,507,094
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $313.3K · FY2012–16$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,507,094 · 1
By mechanism
R01$1,507,094 · 1
Top collaborators
No co-investigators on record.
Most similar at Loyola University Chicago
Same institution · by research overlap
- Dmitry Isaac Gabrilovich$18,046,810
- Liang Qiao$4,617,387
- Fei Shen$55,326
Others in their field
Top investigators on “Accounting”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$185,928,938
- Zeljko Ivezic · University Of Washington$142,654,512
- Victor Krabbendam · Association Of Universities For Research In Astronomy, Inc.$142,654,512
- Steven M Kahn · Association Of Universities For Research In Astronomy, Inc.$142,654,512
Research focus
AccountingBaseBreastBreast Cancer CellCancer Stem CellCell GrowthCell ProliferationCellsCell SurfaceCell SurvivalCessation Of LifeChemotherapyClinical TrialsCytotoxicDesignDiagnosisDisease ProgressionDisease ResistanceDistantEfficacy TrialEndocytosisEpidermal Growth Factor ReceptorEvidence Base2-Tyrosine
Grant awards (5)
Regulation of Notch Signaling by ErbB-2: Novel Therapeutic Strategy$313,325
R01 · FY2016 · CA · contact PI
Regulation of Notch Signaling by ErbB-2: Novel Therapeutic Strategy$313,325
R01 · FY2015 · CA · contact PI
Regulation of Notch Signaling by ErbB-2: Novel Therapeutic Strategy$303,925
R01 · FY2014 · CA · contact PI
Regulation of Notch Signaling by ErbB-2: Novel Therapeutic Strategy$294,526
R01 · FY2013 · CA · contact PI
Regulation of Notch Signaling by ErbB-2: Novel Therapeutic Strategy$281,993
R01 · FY2012 · CA · contact PI